Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/23079588/ below:

Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions

Affiliations

• ¹ Section of Cancer Information, International Agency for Research on Cancer, Lyon, France. soerjomatarami@iarc.fr

• PMID: 23079588
• DOI: 10.1016/S0140-6736(12)60919-2

Item in Clipboard

Isabelle Soerjomataram et al. Lancet. 2012.

• ¹ Section of Cancer Information, International Agency for Research on Cancer, Lyon, France. soerjomatarami@iarc.fr

• PMID: 23079588
• DOI: 10.1016/S0140-6736(12)60919-2

Item in Clipboard

Background: Country comparisons that consider the effect of fatal and non-fatal disease outcomes are needed for health-care planning. We calculated disability-adjusted life-years (DALYs) to estimate the global burden of cancer in 2008.

Methods: We used population-based data, mostly from cancer registries, for incidence, mortality, life expectancy, disease duration, and age at onset and death, alongside proportions of patients who were treated and living with sequelae or regarded as cured, to calculate years of life lost (YLLs) and years lived with disability (YLDs). We used YLLs and YLDs to derive DALYs for 27 sites of cancers in 184 countries in 12 world regions. Estimates were grouped into four categories based on a country's human development index (HDI). We applied zero discounting and uniform age weighting, and age-standardised rates to enable cross-country and regional comparisons.

Findings: Worldwide, an estimated 169·3 million years of healthy life were lost because of cancer in 2008. Colorectal, lung, breast, and prostate cancers were the main contributors to total DALYs in most world regions and caused 18-50% of the total cancer burden. We estimated an additional burden of 25% from infection-related cancers (liver, stomach, and cervical) in sub-Saharan Africa, and 27% in eastern Asia. We noted substantial global differences in the cancer profile of DALYs by country and region; however, YLLs were the most important component of DALYs in all countries and for all cancers, and contributed to more than 90% of the total burden. Nonetheless, low-resource settings had consistently higher YLLs (as a proportion of total DALYs) than did high-resource settings.

Interpretation: Age-adjusted DALYs lost from cancer are substantial, irrespective of world region. The consistently larger proportions of YLLs in low HDI than in high HDI countries indicate substantial inequalities in prognosis after diagnosis, related to degree of human development. Therefore, radical improvement in cancer care is needed in low-resource countries.

Funding: Dutch Scientific Society, Erasmus University Rotterdam, and International Agency for research on Cancer.

Copyright © 2012 Elsevier Ltd. All rights reserved.

PubMed Disclaimer

• Global burden of disease in young people aged 10-24 years: a systematic analysis.

  Gore FM, Bloem PJ, Patton GC, Ferguson J, Joseph V, Coffey C, Sawyer SM, Mathers CD. Gore FM, et al. Lancet. 2011 Jun 18;377(9783):2093-102. doi: 10.1016/S0140-6736(11)60512-6. Epub 2011 Jun 7. Lancet. 2011. PMID: 21652063 Review.

• The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors.

  Mokdad AH, Jaber S, Aziz MI, AlBuhairan F, AlGhaithi A, AlHamad NM, Al-Hooti SN, Al-Jasari A, AlMazroa MA, AlQasmi AM, Alsowaidi S, Asad M, Atkinson C, Badawi A, Bakfalouni T, Barkia A, Biryukov S, El Bcheraoui C, Daoud F, Forouzanfar MH, Gonzalez-Medina D, Hamadeh RR, Hsairi M, Hussein SS, Karam N, Khalifa SE, Khoja TA, Lami F, Leach-Kemon K, Memish ZA, Mokdad AA, Naghavi M, Nasher J, Qasem MB, Shuaib M, Al Thani AA, Al Thani MH, Zamakhshary M, Lopez AD, Murray CJ. Mokdad AH, et al. Lancet. 2014 Jan 25;383(9914):309-20. doi: 10.1016/S0140-6736(13)62189-3. Epub 2014 Jan 20. Lancet. 2014. PMID: 24452042

• Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Dri… See abstract for full author list ➔ Murray CJ, et al. Lancet. 2012 Dec 15;380(9859):2197-223. doi: 10.1016/S0140-6736(12)61689-4. Lancet. 2012. PMID: 23245608
• Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study.

  Murray CJ, Lopez AD. Murray CJ, et al. Lancet. 1997 May 10;349(9062):1347-52. doi: 10.1016/S0140-6736(96)07494-6. Lancet. 1997. PMID: 9149696

• Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

  Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T. Whiteford HA, et al. Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993280 Review.

• Efficacy and safety of Kanglaite injection for gastric cancer: A protocol for systematic review and meta-analysis.

  Hou D, Yang L, Xiong J, Xiong L. Hou D, et al. Medicine (Baltimore). 2020 Aug 7;99(32):e21619. doi: 10.1097/MD.0000000000021619. Medicine (Baltimore). 2020. PMID: 32769923 Free PMC article.

• High Expression of the Long Noncoding RNA SNHG15 in Cancer Tissue Samples Predicts an Unfavorable Prognosis of Cancer Patients: A Meta-Analysis.

  Zhang C, Ke Y, Liu X, Wang X, Li Y, Zhou J, Zhang H, Wang L. Zhang C, et al. J Oncol. 2020 Jul 15;2020:3417036. doi: 10.1155/2020/3417036. eCollection 2020. J Oncol. 2020. PMID: 32733556 Free PMC article.

• Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.

  Fontecha N, Basaras M, Hernáez S, Andía D, Cisterna R. Fontecha N, et al. BMC Cancer. 2016 Nov 5;16(1):852. doi: 10.1186/s12885-016-2885-x. BMC Cancer. 2016. PMID: 27816058 Free PMC article.

• Correlative analysis of gene mutation and clinical features in patients with non-small cell lung cancer.

  Kuang X, Xiao J, Dai LX, Zhang LH, He BX. Kuang X, et al. Transl Cancer Res. 2019 Jun;8(3):736-751. doi: 10.21037/tcr.2019.04.10. Transl Cancer Res. 2019. PMID: 35116812 Free PMC article.

• Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT.

  Chen K, Xu J, Tong YL, Yan JF, Pan Y, Wang WJ, Zheng L, Zheng XX, Hu C, Hu X, Shen X, Chen W. Chen K, et al. Cell Death Dis. 2023 Feb 13;14(2):115. doi: 10.1038/s41419-023-05596-4. Cell Death Dis. 2023. PMID: 36781842 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3